These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 23947677)
1. Expressions of peroxisome proliferator-activated receptors (PPARs) are directly influenced by permeability barrier abrogation and inflammatory cytokines and depressed PPARα modulates expressions of chemokines and epidermal differentiation-related molecules in keratinocytes. Adachi Y; Hatano Y; Sakai T; Fujiwara S Exp Dermatol; 2013 Sep; 22(9):606-8. PubMed ID: 23947677 [TBL] [Abstract][Full Text] [Related]
2. Pseudoceramide stimulates peroxisome proliferator-activated receptor-α expression in a murine model of atopic dermatitis: molecular basis underlying the anti-inflammatory effect and the preventive effect against steroid-induced barrier impairment. Lee SE; Jung MK; Oh SJ; Jeong SK; Lee SH Arch Dermatol Res; 2015 Nov; 307(9):781-92. PubMed ID: 26121942 [TBL] [Abstract][Full Text] [Related]
3. Murine atopic dermatitis responds to peroxisome proliferator-activated receptors alpha and beta/delta (but not gamma) and liver X receptor activators. Hatano Y; Man MQ; Uchida Y; Crumrine D; Mauro TM; Feingold KR; Elias PM; Holleran WM J Allergy Clin Immunol; 2010 Jan; 125(1):160-9.e1-5. PubMed ID: 19818482 [TBL] [Abstract][Full Text] [Related]
4. Keratinocyte differentiation and upregulation of ceramide synthesis induced by an oat lipid extract via the activation of PPAR pathways. Chon SH; Tannahill R; Yao X; Southall MD; Pappas A Exp Dermatol; 2015 Apr; 24(4):290-5. PubMed ID: 25651930 [TBL] [Abstract][Full Text] [Related]
5. Expression of peroxisome proliferator-activated receptors (PPARs) and retinoic acid receptors (RXRs) in rat cortical neurons. Cimini A; Benedetti E; Cristiano L; Sebastiani P; D'Amico MA; D'Angelo B; Di Loreto S Neuroscience; 2005; 130(2):325-37. PubMed ID: 15664689 [TBL] [Abstract][Full Text] [Related]
7. Protective role of peroxisome proliferator-activated receptor α agonists in skin barrier and inflammation. Furue K; Mitoma C; Tsuji G; Furue M Immunobiology; 2018 Mar; 223(3):327-330. PubMed ID: 29111315 [TBL] [Abstract][Full Text] [Related]
8. Panduratin A, an activator of PPAR-α/δ, suppresses the development of oxazolone-induced atopic dermatitis-like symptoms in hairless mice. Kim MS; Pyun HB; Hwang JK Life Sci; 2014 Mar; 100(1):45-54. PubMed ID: 24530874 [TBL] [Abstract][Full Text] [Related]
9. Keratinocyte-derived anosmin-1, an extracellular glycoprotein encoded by the X-linked Kallmann syndrome gene, is involved in modulation of epidermal nerve density in atopic dermatitis. Tengara S; Tominaga M; Kamo A; Taneda K; Negi O; Ogawa H; Takamori K J Dermatol Sci; 2010 Apr; 58(1):64-71. PubMed ID: 20219326 [TBL] [Abstract][Full Text] [Related]
10. Inflammatory reaction versus endogenous peroxisome proliferator-activated receptors expression, re-exploring secondary organ complications of spontaneously hypertensive rats. Sun L; Ke Y; Zhu CY; Tang N; Tian DK; Gao YH; Zheng JP; Bian K Chin Med J (Engl); 2008 Nov; 121(22):2305-11. PubMed ID: 19080338 [TBL] [Abstract][Full Text] [Related]
11. Wy14643, an agonist for PPARα, downregulates expression of TARC and RANTES in cultured human keratinocytes. Zhang W; Sakai T; Fujiwara S; Hatano Y Exp Dermatol; 2017 May; 26(5):457-459. PubMed ID: 27761952 [TBL] [Abstract][Full Text] [Related]
12. Selective expression of a dominant-negative form of peroxisome proliferator-activated receptor in keratinocytes leads to impaired epidermal healing. Michalik L; Feige JN; Gelman L; Pedrazzini T; Keller H; Desvergne B; Wahli W Mol Endocrinol; 2005 Sep; 19(9):2335-48. PubMed ID: 15890673 [TBL] [Abstract][Full Text] [Related]
13. Topical application of PPARα (but not β/δ or γ) suppresses atopic dermatitis in NC/Nga mice. Chiba T; Takeuchi S; Esaki H; Yamamura K; Kurihara Y; Moroi Y; Furue M Allergy; 2012 Jul; 67(7):936-42. PubMed ID: 22583373 [TBL] [Abstract][Full Text] [Related]
14. Peroxisome proliferator-activated receptors (PPARs) and the human skin: importance of PPARs in skin physiology and dermatologic diseases. Sertznig P; Seifert M; Tilgen W; Reichrath J Am J Clin Dermatol; 2008; 9(1):15-31. PubMed ID: 18092840 [TBL] [Abstract][Full Text] [Related]
15. The Expression and Regulation of Interleukin-33 in Human Epidermal Keratinocytes: A New Mediator of Atopic Dermatitis and Its Possible Signaling Pathway. Du HY; Fu HY; Li DN; Qiao Y; Wang QW; Liu W J Interferon Cytokine Res; 2016 Sep; 36(9):552-62. PubMed ID: 27348082 [TBL] [Abstract][Full Text] [Related]
16. Keratinocytes from patients with atopic dermatitis and psoriasis show a distinct chemokine production profile in response to T cell-derived cytokines. Giustizieri ML; Mascia F; Frezzolini A; De Pità O; Chinni LM; Giannetti A; Girolomoni G; Pastore S J Allergy Clin Immunol; 2001 May; 107(5):871-7. PubMed ID: 11344355 [TBL] [Abstract][Full Text] [Related]
17. The effects of Musk T on peroxisome proliferator-activated receptor [PPAR]-alpha activation, epidermal skin homeostasis and dermal hyaluronic acid synthesis. Kim SH; Nam GW; Lee HK; Moon SJ; Chang IS Arch Dermatol Res; 2006 Nov; 298(6):273-82. PubMed ID: 16977445 [TBL] [Abstract][Full Text] [Related]
18. Keratinocyte aquaporin-3 expression induced by histone deacetylase inhibitors is mediated in part by peroxisome proliferator-activated receptors (PPARs). Yang R; Chowdhury S; Choudhary V; Chen X; Bollag WB Exp Dermatol; 2020 Apr; 29(4):380-386. PubMed ID: 32003033 [TBL] [Abstract][Full Text] [Related]
19. Simultaneous effect of ursolic acid and oleanolic acid on epidermal permeability barrier function and epidermal keratinocyte differentiation via peroxisome proliferator-activated receptor-alpha. Lim SW; Hong SP; Jeong SW; Kim B; Bak H; Ryoo HC; Lee SH; Ahn SK J Dermatol; 2007 Sep; 34(9):625-34. PubMed ID: 17727365 [TBL] [Abstract][Full Text] [Related]
20. Intrinsic alterations of pro-inflammatory mediators in unstimulated and TLR-2 stimulated keratinocytes from atopic dermatitis patients. Niebuhr M; Heratizadeh A; Wichmann K; Satzger I; Werfel T Exp Dermatol; 2011 Jun; 20(6):468-72. PubMed ID: 21447101 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]